Tengye Ventures logo

Tengye Ventures

Asia, Beijing, China, Beijing

Description

Tengye Ventures is a professional investment management firm.

Investor Profile

Tengye Ventures has made 4 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series A (25%)

Country Focus

  • China (75%)
  • United States (25%)

Industry Focus

  • Advanced Materials
  • Biotechnology
  • Health Care
  • Electric Vehicle
  • Industrial Manufacturing
  • Aerospace
  • Machinery Manufacturing
  • Manufacturing
  • Technical Support
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Tengye Ventures frequently co-invest with?

Cowin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Crystal Stream Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Co-Investments: 1
Decheng Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Geely
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
sunsail capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Tengye Ventures?

Physcience Golden Silicon is a technology-driven company that develops and manufactures silicon-based anode materials for lithium batteries.

Advanced MaterialsElectric VehicleIndustrial Manufacturing
Series UnknownDec 27, 2024
Zhitian Xinhang

Beijing, Beijing, China

Zhitian Xinhang provides shock absorbers, vibration isolators, sealing rings, and other products.

Advanced MaterialsAerospaceMachinery ManufacturingManufacturingTechnical Support
Series AFeb 17, 2023
Amount Raised: $1,456,092
PackGene Biotech

Houston, Texas, United States

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

BiotechnologyHealth Care
Series BOct 23, 2020
Gan & Lee Pharmaceutical

Beijing, Beijing, China

Gan & Lee pharmaceutical is a Chinese high-tech biopharmaceutical company engaged in the R&D of insulin glargine and insulin lispro.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BMay 1, 2011
Amount Raised: $30,225,682